Stocktoria
Wave Life Sciences Ltd. WVE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-11-11
Chart by TradingView
2/9
Piotroski F — financial health
1.15
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $42.7M | $108.3M | $113.3M | $3.6M | $41.0M |
| Operating income | -$215.4M | -$110.4M | -$68.0M | -$162.7M | -$127.0M |
| Net income | -$204.4M | -$97.0M | -$57.5M | -$161.8M | -$122.2M |
| Operating cash flow | -$187.5M | -$151.0M | -$19.4M | -$127.8M | -$89.0M |
| Free cash flow | -$188.2M | -$152.0M | -$20.5M | -$129.1M | -$89.6M |
| Total assets | $638.5M | $352.2M | $274.9M | $146.4M | $207.0M |
| Total liabilities | $112.3M | $134.8M | $227.4M | $183.6M | $166.6M |
| Shareholders' equity | $518.4M | $209.5M | $39.6M | -$45.1M | $32.5M |
| Ratios | |||||
| Operating margin | -504.1% | -101.9% | -60.0% | -4459.3% | -310.1% |
| Net margin | -478.3% | -89.6% | -50.8% | -4434.7% | -298.4% |
| FCF margin | -440.5% | -140.3% | -18.1% | -3539.1% | -218.6% |
| Return on assets | -32.0% | -27.5% | -20.9% | -110.5% | -59.1% |
| Return on equity | -39.4% | -46.3% | -145.1% | 358.9% | -376.2% |
| Current ratio | 6.47 | 2.89 | 1.26 | 1.38 | 2.53 |
| Revenue growth | -60.5% | -4.4% | 3005.1% | -91.1% | 104.0% |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.15 (grey)
- Working capital / assets 0.814
- Retained earnings / assets -2.077
- EBIT / assets -0.337
- Equity / liabilities 4.617
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001631574 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.